Larger, more concentrated presentation of BIOSTATE® now available

CSL Biotherapies and Australian Red Cross Blood Service are advising the availability of a larger and more concentrated presentation of BIOSTATE® from Monday 21 November 2011.

BIOSTATE® 1,000 IU factor VIII (FVIII) / 2,000 IU von Willebrand factor (vWF), supplied with 10 mL water for injections (100 IU/mL FVIII / 200 IU/mL vWF) was developed by CSL Biotherapies to optimise treatment for people requiring larger doses of BIOSTATE®, in response to requests from the bleeding disorders patient community and healthcare professionals.

Larger doses of BIOSTATE can be prepared from fewer vials and administered in a lower volume dose, thereby shortening reconstitution and infusion times for:

patients and carers who infuse BIOSTATE at home; and,
healthcare professionals who prepare and administer BIOSTATE® in a hospital or clinic setting.

BIOSTATE® 1,000 IU factor VIII (FVIII) / 2,000 IU von Willebrand factor (vWF), supplied with 10 mL WFI 153 KB